Palliative Radiotherapy for Mesothelioma Produces “Substantial Treatment Response”
Doctors in Pennsylvania may have found a way to boost the effectiveness of palliative radiotherapy for pleural mesothelioma. Palliative radiotherapy is used to help with mesothelioma symptoms. It uses lower doses of radiation. Doctors do not expect to treat mesothelioma with palliative radiotherapy. But researchers at the University of Pennsylvania think it could also be a treatment. They combined palliative radiotherapy with a special kind of gene therapy. The gene therapy affects the immune system. They say the combination produced a “substantial treatment response” in a man with mesothelioma. Immuno-gene Therapy and Palliative Radiotherapy Immuno-gene therapy uses genes to stimulate the immune system against cancer. In the new Pennsylvania case study, a 67-year-old man with mesothelioma received immuno-gene therapy. Doctors … Continue reading Palliative Radiotherapy for Mesothelioma Produces “Substantial Treatment Response”
Study Highlights How Genes Impact Mesothelioma Survival
A new National Cancer Institute study shines a light on some of the ways genes impact mesothelioma survival. It could have important implications for mesothelioma treatment. The study was led by prominent mesothelioma researcher Raffit Hassan, MD. It focused on genetic mutations that may make certain mesothelioma patients more sensitive to chemotherapy. Genes, Genotype, and Mesothelioma Treatment A mesothelioma patient’s unique collection of genes, including genetic mutations, is known as their genotype. Genes impact mesothelioma survival in a variety of ways. Tumor suppressor genes are supposed to help keep tumors from forming. People with mutations on these genes may be more likely to get malignant mesothelioma. Other genes influence the cancer’s ability to “hide” from detection by the immune system. … Continue reading Study Highlights How Genes Impact Mesothelioma Survival
MIT Study Could Open Door for Inhalable Mesothelioma Treatment
New lung cancer research might help pave the way for an inhalable mesothelioma treatment. MIT cancer researchers teamed up with chemical engineers to test a new method for delivering genetic instructions to lung cells. Mice that inhaled a formula designed to “tell” their lung cells to produce more of a certain protein did exactly that. The team says it’s proof that this could be a viable method for treating cancer in the lungs. Pleural mesothelioma is a lung-related cancer caused by inhaled asbestos. How Would an Inhalable Mesothelioma Treatment Work? The study was led by scientists at MIT’s Koch Center for Integrative Cancer Research. It is based on two things scientists already know about cancer treatment. One is that inhalation … Continue reading MIT Study Could Open Door for Inhalable Mesothelioma Treatment
Genetics-Based Cancer Treatment Could Mean New Hope for Mesothelioma
The FDA has approved a new genetics-based cancer treatment that could open the door for more targeted mesothelioma therapy. The drug is called larotrectinib. The drug company Bayer sells it under the brand name Vitrakvi. Larotrectinib is unique because it is not specific to any one type of cancer. Instead, larotrectinib is based on a patient’s genetic biomarkers. It is the first drug of its kind to gain approval by the FDA. What is a Genetics-Based Cancer Treatment? A genetics-based cancer treatment is a drug that targets certain genetic mutations. Doctors find these mutations by testing for biomarkers. One mutation could cause breast cancer, colon cancer, or even pleural mesothelioma. Some kinds of mutations are connected to only one type … Continue reading Genetics-Based Cancer Treatment Could Mean New Hope for Mesothelioma
New Study Sheds Light on Genetic Origins of Malignant Mesothelioma
Scientists in Australia have made a big step forward in understanding how a genetic mutation appears to drive the development of cancers such as malignant mesothelioma. The gene in question is called p53. Also known as the “guardian of the genome” for its tumor-suppressing action, p53 has been found to be mutated in about half of all human cancers, including many cases of mesothelioma. Although the primary external cause of mesothelioma is exposure to asbestos, the mutated p53 gene helps explain why some asbestos-exposed cells suddenly become cancerous and are able to grow and spread, unchecked. It may also help scientists develop new, more effective mesothelioma treatments. Right now, the prognosis for mesothelioma is often very poor. The p53 Gene … Continue reading New Study Sheds Light on Genetic Origins of Malignant Mesothelioma
New Data Suggest a Mesothelioma Blood Test is Possible
A new technology that looks for genetic material from cancer cells in the blood could open the door to the fastest, easiest way yet to diagnose early malignant pleural mesothelioma. The test, which has already shown potential for early detection of lung cancer, was developed by a California-based life sciences company called GRAIL. GRAIL-funded researchers shared the data on the test at the American Society of Clinical Oncology annual meeting this summer in Chicago. The results are part of the preliminary data from the company’s ongoing Circulating Cell-Free Genome Atlas study, a huge study on cancer diagnosis that aims to enroll 15,000 people (70 percent with cancer and 30 percent without) from 141 sites in the US and Canada. “We’re … Continue reading New Data Suggest a Mesothelioma Blood Test is Possible
Pleural Mesothelioma Risk: Genes and Exposure Both Play a Role
When it comes to the development of malignant pleural mesothelioma, your job and your relatives both appear to play critical roles. A new study in the European Journal of Cancer points to the interplay between environment and genetics in the development of the asbestos cancer. The study shows, once again, just how destructive asbestos can be to human health. Analyzing Mesothelioma Incidence Among Swedes The new research used data from the Swedish Family-Cancer Database, which includes all Swedes born after 1931 and their biological parents – a total of 16.1 million people, including 2.3 million cancer patients. After analyzing the data on all people with pleural mesothelioma, the researchers determined that those who worked around asbestos were more than three … Continue reading Pleural Mesothelioma Risk: Genes and Exposure Both Play a Role
Telomere Length May Be Key to Earlier Detection of Pleural Mesothelioma
Japanese pathologists have a new theory that may lead to earlier detection and better outcomes for people with malignant pleural mesothelioma. Researchers led by the International University of Health and Welfare in Tokyo say exposure to asbestos appears to shorten the telomeres that protect the ends of DNA strands. The discovery could give doctors another way to diagnose malignant mesothelioma in time to implement more effective treatments. What are Telomeres? Telomeres are the caps on the end of each strand of DNA. According to Telomere Activation Sciences, telomeres function like the plastic tips on the ends of shoelaces. Like those tips, telomeres help protect chromosomes from becoming frayed and damaged. When DNA is damaged, normal cellular processes are disrupted and … Continue reading Telomere Length May Be Key to Earlier Detection of Pleural Mesothelioma
Peritoneal Mesothelioma Case Highlights Importance of Genetic Testing
The case of a peritoneal mesothelioma patient who was diagnosed at just 45-years-old is drawing attention to the role of genetics in this aggressive asbestos-linked malignancy. Sometimes referred to as “asbestos cancer”, malignant mesothelioma is almost always connected with known exposure to the fibrous mineral—often in a work environment. But even though most mesothelioma cases can be traced back to asbestos, not all asbestos-exposed people go on to develop malignant mesothelioma. Because of this, scientists began to believe that, in mesothelioma as in so many other types of cancer, there were likely other factors at play. Early Mesothelioma, Genes, and Asbestos Exposure In most cases, mesothelioma takes decades to develop, meaning that most patients are not diagnosed with mesothelioma until they … Continue reading Peritoneal Mesothelioma Case Highlights Importance of Genetic Testing
BAP1 Not the Only Genetic Risk Factor for Mesothelioma
A new study suggests that the BAP1 gene, which has been linked to several kinds of cancer including malignant mesothelioma, may not be the only genetic risk factor for the asbestos cancer. Mesothelioma, a fast-growing membrane cancer, typically only occurs in people who have a history of asbestos exposure. But scientists have long wondered why some asbestos-exposed people go on to develop pleural or peritoneal mesothelioma while others don’t. Extensive mesothelioma research, much of it focused on a mesothelioma “epidemic” among extended families in a particular region in Turkey, discovered that many family members who contracted mesothelioma shared a mutation on the BAP1 gene. This genetic anomaly has also been associated with an increased risk for uveal melanoma, renal cell carcinoma … Continue reading BAP1 Not the Only Genetic Risk Factor for Mesothelioma
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!